Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

FD acquires QuantumKDB

12 Jan 2016 07:00

RNS Number : 5189L
First Derivatives PLC
12 January 2016
 

12 January 2016

 

First Derivatives plc

("FD", the "Company" or the "Group")

 

FD acquires QuantumKDB

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services, announces that it has acquired the entire issued share capital of QuantumKDB (UK) Limited ("Quantum") for total consideration of up to £2.2m. The acquisition provides the Group with complementary consultancy expertise to support the growth of its Kx business and is expected to be earnings enhancing in the first full year following acquisition*.

 

Acquisition rationale

 

Quantum was founded in 2011 by its CEO Kieran Lucid and provides Kx consulting in the UK, US and Hong Kong. The majority of its clients operate in capital markets and the acquisition will strengthen the Group's relationship with certain key clients as well as adding to the existing customer base. Quantum has a total of 15 consultants with strong experience in Kx technology. In its latest financial year to 13 September 2015, Quantum reported profit before tax of £0.3m and had net assets of £0.25m at acquisition.

 

Terms of the Acquisition

 

The initial consideration for the acquisition is £1.7m of which £0.6m is payable in cash and £1.1m is payable through the issue of 72,940 new ordinary shares in FD (the "Consideration Shares"). Deferred consideration of up to £0.5m is payable on the achievement of certain targets on the 12 month anniversary of the acquisition.

 

Application has been made for the 72,940 Consideration Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 15 January 2016. The Consideration Shares will rank pari passu with the Company's existing ordinary shares in issue. Following this allotment, the total issued share capital of the Company will increase to 23,921,972 ordinary shares.

 

Kieran Lucid, Chief Executive Officer of Quantum, commented: "As the home of Kx technology, FD is a natural fit for us. We are joining at a time of rapid expansion in the Kx client base across industry sectors, as more and more clients appreciate the benefits of this technology that has dominated capital markets for more than 10 years. We are excited about drawing on the expertise we've gained to assist the Group in its ambitious plans for the future."

 

Brian Conlon, Chief Executive Officer of FD, commented: "We are experiencing increasing demand for Kx skills from existing and potential customers and the acquisition of Quantum will add to our existing capabilities and support our growth plans. We welcome its staff to the Group."

 

\* This statement does not constitute a profit forecast.

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc

(Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

 

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,500 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAEFFFELKEAF
Date   Source Headline
11th Feb 20144:18 pmRNSDirector's Shareholding
10th Feb 20147:00 amRNSIssue of Equity
6th Feb 20147:00 amRNSOpening of Singapore Office
20th Jan 20147:00 amRNSDirector/PDMR Shareholding
31st Dec 201311:08 amRNSTotal Voting Rights
20th Dec 20134:33 pmRNSIssue of Equity
5th Dec 20137:00 amRNSEnterprise Securities Market Notice
29th Nov 20134:00 pmRNSIssue of Equity
26th Nov 20137:00 amRNSASIC goes live with new surveillance system
5th Nov 20137:00 amRNSInterim Results
23rd Oct 20137:00 amRNSNotice of Results
30th Sep 20131:34 pmRNSTotal Voting Rights
18th Sep 20131:01 pmRNSCollaboration with NYSE Technologies
11th Sep 20137:00 amRNSEnterprise Securities Market Notice
10th Sep 20137:00 amRNSContract Win
5th Sep 20132:41 pmRNSIssue of Equity
30th Aug 20131:05 pmRNSTotal Voting Rights
21st Aug 20137:00 amRNSDelta Stream Selected by Communications Provider
14th Aug 20137:00 amRNSEnterprise Securities Market Notice
8th Aug 201312:53 pmRNSIssue of Equity
18th Jul 201312:55 pmRNSResult of AGM
9th Jul 20137:00 amRNSEnterprise Securities Market Notice
5th Jul 20134:11 pmRNSHolding(s) in Company
5th Jul 20134:10 pmRNSHolding(s) in Company
3rd Jul 20133:18 pmRNSIssue of Equity
3rd Jul 20137:00 amRNSEnterprise Securities Market Notice
28th Jun 20137:00 amRNSPlacing of 840,000 new ordinary shares
18th Jun 20137:00 amRNSFinal Results
5th Jun 20137:00 amRNSNotice of Results
9th May 20137:00 amRNSBoard restructuring
30th Apr 20138:00 amRNSTotal Voting Rights
26th Apr 20133:54 pmRNSEnterprise Securities Market Notice
23rd Apr 20137:00 amRNSEnterprise Securities Market Notice
19th Apr 20137:30 amRNSChange in Directors Shareholding
19th Apr 20137:30 amRNSGrant of Options
17th Apr 20133:10 pmRNSIssue of Equity
3rd Apr 20133:40 pmRNSDirector's Shareholding
2nd Apr 20137:00 amRNSPre-close period trading update
15th Mar 20137:00 amRNSSEF initiative & Compliance Officer appointment
28th Feb 20137:00 amRNSTotal Voting Rights
11th Feb 20137:00 amRNSEnterprise Securities Market Notice
6th Feb 20137:00 amRNSExercise of Options
4th Jan 20133:41 pmRNSDirector/PDMR Shareholding
13th Dec 20127:00 amRNSContract win
10th Dec 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSTotal Voting Rights
16th Nov 20127:00 amRNSEnterprise Securities Market Notice
14th Nov 20127:00 amRNSDirector shareholding
13th Nov 20127:00 amRNSDirector shareholding
12th Nov 20123:24 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.